European Court Opens Door for Stem Cell Patenting
By GEN,
Genetic Engineering & Biotechnology News
| 12. 18. 2014
Today the European Court of Justice (CJEU) ruled that human embryonic stem cell patents could be allowed if organisms can't develop into human being. The decision overturns a 2011 European Union ruling that outlawed patents on hESC research, affirming that pluripotent human stem cells derived from parthoenogenetically activated oocytes can be patented in Europe.
Parthenogenesis refers to the initiation of embryogenesis without fertilization by oocyte activation in the absence of sperm though a variety of chemical and electrical techniques. The activated oocyte contains a single or double set of maternally derived chromosomes but does not contain paternal DNA.
While patents on hESC have been upheld in the United States, the European Patent Office (EPO) has refused to grant many of the same patents on ethical grounds if the commercial exploitation of those patents goes against public order or morality. Combined with a principle of noncommercialization of the human embryo, human body, and its products led Europe to deny the patentability of hESC.
Today’s judgment was precipitated though an appeal brought by International Stem Cell Corporation (ISC), a California-based biotechnology company...
Related Articles
By Emily Baumgaertner Nunn, The New York Times | 06.30.2026
A research program at the National Institutes of Health released the world’s largest database of human genomes and paired them with clinical data, officials announced Tuesday, paving the way for a new era of study in personalized medicine.
The All...
The title of this book is clever, not least because it is borrowed from a very secret society of a dozen Stanford students. Theo Baker, a gregarious computer science freshman, was interviewed by the hyper-rich anonymous entrepreneur who quietly assembled the members. The unspoken suggestion was that he might consider hiring some of the members in service of acquiring his next billion. (Either Baker was not offered a place or he is not admitting it.) Such are the ways of...
By Carl Zimmer, The New York Times | 06.04.2026
Scientists at Columbia University have edited the DNA of early human embryos with unprecedented accuracy, an achievement that could open the way to babies engineered with particular characteristics.
The prospect has fueled controversy for years. On the one hand, the...
By Calder McHugh, Politico | 05.15.2026
There will come a time, in the not-so-distant future, when you decide to stick a computer chip in your brain.
At least, that’s what D. Scott Phoenix told the audience at TED 2026 in Vancouver last month.
“Someone you work...
